Impact of geriatric assessment tools on 1- year mortality in non-metastatic breast cancer patients 65 years and older
Not Applicable
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2021/07/034792
- Lead Sponsor
- Tata Memorial Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
a study of geriatric breast cancer patients
Exclusion Criteria
1.Not willing to participate
2.Unable to understand the questionnaires
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cumulative incidence of 1 year mortality.Timepoint: 1 year
- Secondary Outcome Measures
Name Time Method 1.Validation of MPI and Onco-MPI for 1-year mortality. <br/ ><br>2.Comparison of outcome using MPI and Onco-MPI with conventional prognostic factors. <br/ ><br>3.To study quality-of-life using the WHO BREF questionnaire pre- and post-treatment. <br/ ><br>4.To study the impact of cancer treatment on the systemic organ functions pre-and post-treatment. <br/ ><br>5.Sensitivity of G8 and VES-13 as screening tools for geriatric assessment <br/ ><br>6.2-year mortality <br/ ><br>Timepoint: 2 year